About Us

Chongqing Fuan Pharmaceutical Co., Ltd.

Chongqing Fuan Pharmaceutical Co., Ltd., established on 24 Feb., 2004, is a modern pharmaceutical enterprise located in Chongqing (Changshou) Chemial Park, and is mainly engaged in the manufacture and sales of APIs in accordance with the related national standards and GMP standard. With an occupied floor area of 100mu, a construction area of 4,000 sq. meters and first-stage investment of more than 34 million RMB yuan, the company consists of two antibiotics workshops, office buildings and supporting facilities. After completion, the company will have a continuous line of raw materials--semi-finished products--end products. And the company will apply for its own trademark and directly provide finished pharmaceuticals with its own trademark.

Our holding company is Chongqing Biological Products Co., Ltd., which has effectively cooperated with many domestic and overseas research institutes and universities to establish a platform for the going global of Chongqing Fuan Pharmaceutical Co., Ltd.

The company has successfully developed such four new APIs as aztreonam, ticarcillin sodium, sulbenicillin disodium, cefpirome sulfate, among which, ticarcillin sodium, cefpirome sulfate are of the national new drugs and have attained the New Drug Certificate. The annual production capacity of these 4 new APIs can reach 10 tons or so with an annual production value of 100 million RMB yuan. The company, as planned, has started the research project of more than 20 medium-to-high-end products, which are estimated to be put into the market in 3 years' time. In addition to antibiotics, we have also been involved in other areas, such as fine chemicals and special-use chemicals etc.

While keep improving our services, we have been always committed ourselves to the sales of our products in the domestic market. And the company has attained the import & export power, and always seeks to cooperate with foreign trade companies to expand our business to other countries.

The company has 100 employees, and part of our management staff are very experienced in the research of famciclovir, penciclovir, cefradine,tolterodine etc. The company attaches great importance to the establishment of the corporate culture, the training and the welfare of employees and good teamwork.

The company will continuously commit itself to the R & D of new drugs, and to the integration of research, manufacture and sales, to survive the fierce competition in the pharmaceuticals market.